Drugs / Drotaverine
last change Jan 2013 re-read 2 minutes ago

Drotaverine

Small molecule

Developed for
dysmenorrhea · cervix disorder
Investigated by
Ain Shams University · Changhai Hospital · Sanofi

Trials 3 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01236651 Nov 2010 → Apr 2011 Ain Shams University Unknown No outcome recorded
Phase 31 trial
Phase 3 NCT00731198 Aug 2008 → Mar 2009 bile duct disorder, pancreas disorder Changhai Hospital Completed No outcome recorded
Phase 41 trial
Phase 4 NCT00292747 May 2005 → Feb 2006 dysmenorrhea Sanofi Terminated No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT01639027 Comparator May → Dec 2012 cervix disorder, perinatal asphyxia Ain Shams Maternity Hospital Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Drotaverine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01236651
2

NCT01639027

NCT00292747

Known as Do-Spa “to make the yellowish colored Drotaverine Hydrochloride (Do-Spa®) in-differentiable from the translucent saline solution.” NCT01639027
Known as Drotaverin ChEMBL registry synonym — accepted as the source's own label CHEMBL551978
Known as Drotaverina ChEMBL registry synonym — accepted as the source's own label CHEMBL551978
Known as Drotaverine Hydrochloride “Each participant will randomly take a prefilled syringe with two milliliters of the study medication solution (either Drotaverine Hydrochloride or saline).” NCT01639027
1

NCT00731198

Known as Drotin ChEMBL registry synonym — accepted as the source's own label CHEMBL551978
Action Inhibit “selectively inhibits phosphodiesterase IV” NCT00731198
Modality Small molecule “Drotaverine, an isoquinolone derivative” NCT01639027
Route Oral “Drotaverine 80 mg plus ibuprofen placebo orally” NCT00292747